chloroquine has been researched along with purfalcamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, C; Breton, G; Bursulaya, B; Chatterjee, A; Gray, N; Harper, J; Henson, K; Johnson, J; Kato, N; Kumar, KA; Le Roch, KG; Marr, F; Mason, D; McNamara, C; Nagle, A; Peters, EC; Plouffe, D; Ramachandran, V; Sakata, T; Schultz, PG; Spooner, M; Tuntland, T; Ward, GE; Winzeler, EA; Zhou, Y | 1 |
1 other study(ies) available for chloroquine and purfalcamine
| Article | Year |
|---|---|
Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility.
Topics: Adenine; Animals; Antimalarials; Cell Line; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Cyclohexylamines; Drug Evaluation, Preclinical; Enzyme Activation; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Molecular Weight; Movement; Oligonucleotide Array Sequence Analysis; Parasitic Sensitivity Tests; Plasmodium falciparum; Protein Kinases; Protozoan Proteins; Recombinant Proteins; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution | 2008 |